Back-Up Supplier Strategy for High-Risk Investigational Products in Clinical Trials
Back-Up Supplier Strategy for High-Risk Investigational Products in Clinical Trials Creating a Back-Up Supplier Strategy for High-Risk Investigational Products Investigational products (IPs), especially biologics, niche molecules, or temperature-sensitive materials, are critical to the success of a clinical trial. Any disruption in their supply can jeopardize trial timelines, regulatory compliance, and patient safety. This tutorial provides…
Read More “Back-Up Supplier Strategy for High-Risk Investigational Products in Clinical Trials” »
